Doctor profile · Federal record
Dr. DANIEL BRENNER, MD / PHD
Cardiovascular Disease Physician (CMS: INTERVENTIONAL CARDIOLOGY) · SANTA ROSA, CA
- NPI 1750561973
- Accepts Medicare
- 19 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
34 MARK WEST SPRINGS RD STE 310
SANTA ROSA, CA 95403
(617) 573-5200
fax (808) 576-5417 - Additional location
-
3288 Moanalua Rd, Department of Cardiology, 3rd Floor
Honolulu, HI 968191469
(808) 432-8000
fax (808) 432-8385
Credentials & registration
- NPI registered
- November 2007 — 19 yrs on file
- Profile last updated
- November 5, 2018
- Year of graduation
- 2007 — 19 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State license (1)
- California #A105376
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1750561973. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,089
Distinct HCPCS
10
Medicare allowed
$444,804
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 667 | 564 | $16 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 630 | 478 | $140 | |
99152 |
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 196 | 188 | $13 | |
A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose | 195 | 99 | $96 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 181 | 172 | $73 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 168 | 94 | $126 | |
93296 |
Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 157 | 76 | $27 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 126 | 121 | $223 | |
93294 |
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 103 | 52 | $32 | |
93458 |
Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 102 | 101 | $251 |
In context: peer comparison
Among 10 peers in this city , average services per provider: 150. This provider delivers 27× the peer median.Open Payments
Industry payments received
All-time total
$894
Transactions
27
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABIOMED | 3 | $192.10 | |
| Philips North America LLC | 8 | $175.76 | |
| Edwards Lifesciences Corporation | 1 | $140.16 | |
| Medtronic, Inc. | 3 | $85.61 | |
| HEARTFLOW, INC. | 2 | $71.70 | |
| Abbott Laboratories | 2 | $71.33 | |
| Boston Scientific Corporation | 2 | $68.98 | |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $41.68 | |
| Terumo Medical Corporation | 1 | $28.05 | |
| SANOFI-AVENTIS U.S. LLC | 1 | $18.22 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
4,457
Patients
1,354
Total drug cost
$1,091,130
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Atorvastatin Calcium | Generic | 933 | 287 | $15,770 |
| Metoprolol Succinate | Generic | 481 | 146 | $8,355 |
| Eliquis (Apixaban) | Brand | 427 | 106 | $477,889 |
| Entresto (Sacubitril/Valsartan) | Brand | 410 | 111 | $415,285 |
| Losartan Potassium | Generic | 328 | 104 | $5,034 |
| Clopidogrel (Clopidogrel Bisulfate) | Brand | 263 | 88 | $5,467 |
| Spironolactone | Generic | 258 | 77 | $3,304 |
| Rosuvastatin Calcium | Generic | 255 | 78 | $7,840 |
| Amlodipine Besylate | Generic | 243 | 81 | $2,859 |
| Lisinopril | Generic | 230 | 67 | $3,206 |